Loading...
Chlorpromazine versus lithium for people with schizophrenia
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To investigate the effects of chlorpromazine alone versus lithium alone in the treatment of schizophrenia, schizophrenia-like psychoses and schizoaffective psychoses. It is expected that the implementation of several subgroup analyses may be possible (see Subgroup analysis and investigation of heterogeneity). © 2017 The Cochrane Collaboration. Published by JohnWiley & Sons, Ltd.
Citations
Altmetric:
Date
2017
Type
Article
Subject
Drug therapy, Schizophrenia
Collections
Citation
Cardoso, D., Tyrrell, K., Mancias Guerra, C. & Rikhraj, S. (2017). Chlorpromazine versus lithium for people with schizophrenia. Cochrane Database of Systematic Reviews, 2017 (7), pp.1-13.
Journal / Source Title
DOI
PMID
Publisher
Publisher’s URL
Publisher’s statement
Files
Loading...
Cardoso 2017 1-13.pdf
Adobe PDF, 245.19 KB